Motus GI to Present at the Piper Jaffray Healthcare Conference
November 20 2018 - 8:00AM
Business Wire
– Fireside chat with live audio webcast
Thursday, November 29, 2018 at 10:00 a.m. EST –
Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the
"Company"), a medical technology company dedicated to improving
clinical outcomes and enhancing the cost-efficiency of colonoscopy,
announced today that Tim Moran, Chief Executive Officer, will
provide a corporate overview during a fireside chat at the Piper
Jaffray Healthcare Conference on Thursday, November 29, 2018 at
10:00 a.m. EST in New York, NY.
A live audio webcast of the fireside chat will be accessible on
the Events page of the Investors section on the Company's website
at www.motusgi.com. The webcast replay will be available
approximately two hours after the presentation ends and will be
accessible for 90 days.
About Motus GI and the Pure-Vu® System
Motus GI Holdings, Inc. is a medical technology company, with
subsidiaries in the U.S. and Israel, dedicated to improving
clinical outcomes and enhancing the cost-efficiency of colonoscopy.
The Company’s flagship product is the Pure-Vu® System, a U.S. FDA
cleared medical device indicated to help facilitate the cleaning of
a poorly prepared colon during the colonoscopy procedure. The
device integrates with standard and slim colonoscopes to enable
safe and rapid cleansing during the procedure while preserving
established procedural workflow and techniques. The Pure-Vu® System
has received CE mark approval in Europe. The Pure-Vu® System is
currently being introduced on a pilot basis in the U.S. market, and
the Company is planning to initiate a full commercial launch
focused on the inpatient colonoscopy market in the U.S. and select
international markets in 2019. Challenges with bowel preparation
for inpatient colonoscopy represent a significant area of unmet
need that directly affects clinical outcomes and increases the cost
of care in a market segment that comprises approximately 1.5
million annual procedures in the U.S. and approximately 4 million
annual procedures worldwide. Motus GI believes the Pure-Vu® System
may improve outcomes and lower costs for hospitals by reducing the
time to successful colonoscopy, minimizing delayed and incomplete
procedures, and improving the quality of an exam. In clinical
studies to date, the Pure-Vu® System significantly increased the
number of patients with an adequate cleansing level, according to
the Boston Bowel Preparation Scale Score, a validated assessment
instrument.
For more information, visit www.motusgi.com and connect with the
Company on Twitter, LinkedIn and Facebook.
Forward-Looking Statements
This press release contains certain forward-looking statements.
Forward-looking statements are based on the Company's current
expectations and assumptions. The Private Securities Litigation
Reform Act of 1995 provides a safe-harbor for forward-looking
statements. These statements may be identified by the use of
forward-looking expressions, including, but not limited to,
"expect," "anticipate," "intend," "plan," "believe," "estimate,"
"potential," "predict," "project," "should," "would" and similar
expressions and the negatives of those terms, including without
limitation, risks inherent in the development and commercialization
of potential products, uncertainty in the timing and results of
clinical trials or regulatory approvals, maintenance of
intellectual property rights or other risks discussed in the
Company’s Form 10-K filed on March 28, 2018, and its other filings
with the Securities and Exchange Commission. Prospective investors
are cautioned not to place undue reliance on such forward-looking
statements, which speak only as of the date hereof. The Company
undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20181120005049/en/
Investor and Media
Contact:Jenene ThomasJenene Thomas Communications,
LLC(833) 475-8247mots@jtcir.com
Motus GI (NASDAQ:MOTS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Motus GI (NASDAQ:MOTS)
Historical Stock Chart
From Apr 2023 to Apr 2024